Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of KRT19 monoclonal antibody, clone SB39g
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Mouse |
| Applications | WB,ELISA,IHC-Fr,IF |
More info about KRT19 monoclonal antibody, clone SB39g
| Brand: | Abnova |
| Reference: | MAB5631 |
| Product name: | KRT19 monoclonal antibody, clone SB39g |
| Product description: | Mouse monoclonal antibody raised against partial recombinant KRT19. |
| Clone: | SB39g |
| Isotype: | IgG2a |
| Gene id: | 3880 |
| Gene name: | KRT19 |
| Gene alias: | CK19|K19|K1CS|MGC15366 |
| Gene description: | keratin 19 |
| Immunogen: | Recombinant protein corresponding to C-terminus of human KRT19. |
| Form: | Liquid |
| Recommend dilutions: | Immunohistochemistry (10 ug/mL) Western Blot (1:2000-1:4000) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In 100 mM BBS, pH 8.2 |
| Storage instruction: | Store at 4°C. |
| Product type: | Primary antibodies |
| Host species: | Mouse |
| Antigen species / target species: | Human |
| Specificity: | Cytokeratin 19. |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | Cell cytospin of the HCC38 breast carcinoma cell line was incubated with KRT19 monoclonal antibody, clone SB39g (Cat # MAB5631). After washing, a 10 ug/mL dilution of goat anti-mouse Ig-FITC was used for immunofluorescence staining. Positive cells were viewed by fluorescence microscopy. |
| Applications: | WB,ELISA,IHC-Fr,IF |
| Shipping condition: | Blue Ice |
| Publications: | Expression of cytokeratin 19 in human hepatocellular carcinoma cell lines.Wu F, Nishioka M, Fujita J, Murota M, Ohtsuki Y, Ishida T, Kuriyama S. Int J Oncol. 2002 Jan;20(1):31-7. |